Assess EF Either DC or pharmacological cardioversion is acceptable safe and effective DC cardioversion is more effective but involves risk of anesthesia sedation Thromboembolic risks and considerations for anticoagulation still apply Consider catheter abl

By rray, 26 January, 2024
Exclude Patient Type Detail Header
No
Footnote
<sup>1</sup> Hindricks G, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. <i>Eur Heart J.</i> 2021 Feb 1;42(5):373-498. <a href=https://academic.oup.com/eurheartj/advance-article-pdf/doi/10.1093/eurheartj/ehaa612/33799442/ehaa612.pdf><u>Free, full-text PDF</u></a>
Detail Type
Text
Patient Type Detail Header (Long)
Assess EF. Either DC or pharmacological cardioversion is acceptable, safe, and effective. DC cardioversion is more effective but involves risk of anesthesia/sedation. Thromboembolic risks and considerations for anticoagulation still apply. Consider catheter ablation.